APYX
Apyx Medical Inc
2.60$
+0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 55.2% | 56.1% | 62.5% | 47.8% | 46.3% | 49.8% | 57.8% | 57.0% | 61.1% | 62.6% | 60.3% | 60.7% | 57.8% | 56.0% | 58.8% | 57.8% | 59.0% | 61.1% | 67.5% | 57.5% | 51.1% | 49.2% | 35.3% | 32.4% | 36.8% | 30.7% | 34.6% | 35.5% | 39.0% | 64.0% | |
| 44.8% | 43.9% | 37.5% | 52.2% | 53.7% | 50.2% | 42.2% | 43.0% | 38.9% | 37.4% | 39.7% | 39.3% | 42.2% | 44.0% | 41.2% | 42.2% | 41.0% | 38.9% | 32.5% | 42.5% | 48.9% | 50.8% | 64.7% | 67.6% | 63.2% | 69.3% | 65.4% | 64.5% | 61.0% | 36.0% | |
| 1.4% | 1.3% | 2.2% | 4.0% | 5.2% | 4.0% | 5.6% | 4.3% | 4.4% | 4.9% | 4.4% | 5.7% | 7.3% | 7.7% | 7.7% | 4.7% | 4.8% | 5.3% | 5.1% | 7.3% | 7.1% | 6.3% | 14.8% | 13.2% | 14.1% | 8.9% | 10.2% | 9.3% | 10.6% | 6.4% | |
| 17.9% | – | 20.8% | 67.3% | 39.3% | 41.0% | 39.5% | 33.9% | 28.1% | 28.5% | 25.5% | 26.3% | 30.2% | 33.6% | 39.6% | 40.5% | 32.4% | 42.1% | 48.5% | 58.9% | 52.1% | 54.1% | 127.0% | 128.3% | 121.5% | 90.1% | 108.2% | 93.3% | 89.7% | 68.3% | |
| 38.4% | 39.2% | 48.4% | 74.6% | 48.4% | 45.1% | 46.0% | 38.7% | 32.7% | 35.4% | 29.9% | 32.0% | 37.6% | 41.3% | 47.3% | 45.3% | 37.2% | 47.4% | 53.6% | 66.2% | 59.3% | 60.4% | 141.7% | 141.5% | 135.6% | 99.0% | 118.4% | 97.5% | 100.2% | 48.2% | |
| 6.4% | 4.6% | -10.9% | -22.4% | 5.3% | 5.1% | -3.8% | 4.3% | 6.2% | 2.0% | 9.8% | 7.3% | 4.6% | 2.7% | -11.4% | -0.1% | 3.8% | -15.5% | -21.1% | -23.7% | -10.4% | -13.5% | -81.5% | -73.9% | -72.5% | -29.8% | -52.9% | -33.0% | -39.2% | -12.2% | |
| 1.0% | 0.0% | 1.2% | 0.0% | 0.7% | 0.6% | 0.4% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 0.2% | 0.3% | 0.9% | 1.0% | 0.8% | 1.0% | 0.5% | 0.5% | 0.4% | 0.3% | 0.6% | 0.0% | 0.2% | 0.0% | 0.0% | 4.7% | 12.3% | 10.6% | |
| 5.6% | 1.3% | -11.8% | -22.3% | 5.4% | 1.7% | -4.1% | 4.1% | 6.2% | 2.1% | 10.2% | 7.8% | 9.9% | 2.5% | -10.2% | 0.1% | 3.0% | -25.2% | -48.0% | -18.1% | -10.6% | -13.4% | -79.5% | -70.3% | -70.0% | -30.5% | -51.5% | -40.7% | -48.5% | -20.5% | |
| -0.9% | 3.3% | 0.9% | 0.4% | 0.3% | -1.8% | 0.3% | 0.2% | -1.3% | 0.2% | 0.2% | -0.5% | 3.4% | 0.2% | -3.8% | -0.3% | 0.8% | -6.8% | 14.4% | 0.1% | 0.2% | -0.4% | -22.6% | -0.5% | -27.1% | 0.8% | 0.8% | -4.6% | 0.5% | 0.5% | |
| 5.4% | 1.3% | -11.8% | -22.8% | 5.0% | 6.8% | -4.1% | 4.1% | 7.4% | 2.0% | 10.1% | 8.3% | 6.5% | 2.2% | -6.3% | 0.4% | 2.2% | -18.3% | -62.4% | -18.2% | -10.8% | -13.0% | 383.6% | -69.8% | -42.9% | -31.3% | -52.1% | -35.7% | -48.8% | -21.2% | |
| 9.9% | 8.4% | -1.6% | 9.9% | 9.3% | 10.1% | -1.6% | 6.7% | 8.2% | 4.7% | 11.8% | 10.0% | 13.6% | 6.6% | -5.1% | 4.7% | 7.0% | -15.6% | -18.0% | -20.9% | -8.3% | -33.4% | -83.4% | -67.6% | -66.7% | -28.7% | -49.4% | -34.6% | -34.9% | -8.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.